This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Lora Eshkar-Sebban: Innovator in Biopharmaceuticals
Introduction
Lora Eshkar-Sebban is a prominent inventor based in Beit Hasmonai, Israel. She has made significant contributions to the field of biopharmaceuticals, particularly through her innovative work on polypeptides.
Latest Patents
Lora holds 2 patents related to isolated polypeptides of CD44. Her latest patents focus on the development of isolated polypeptides that consist of specific amino acid sequences. These polypeptides have been shown to possess anti-inflammatory activity, making them valuable in the treatment of inflammatory diseases. The patents also include compositions of matter, fusion proteins, and pharmaceutical formulations that utilize these isolated polypeptides.
Career Highlights
Throughout her career, Lora has worked with notable organizations, including Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Nutrinia, Ltd. Her work has been instrumental in advancing research and development in her field.
Collaborations
Lora has collaborated with esteemed colleagues such as David Naor and Keren-Or Amar, contributing to a dynamic research environment that fosters innovation.
Conclusion
Lora Eshkar-Sebban's contributions to the field of biopharmaceuticals through her patents and collaborations highlight her role as a leading inventor. Her work continues to impact the treatment of inflammatory diseases and showcases the importance of innovation in healthcare.